Novo Nordisk first out of the gate with oral weight-loss drug, and its stock jumpsMarket Watch • 12/23/25
Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss DrugInvestors Business Daily • 12/22/25
The FDA has approved the first GLP-1 pill for weight loss, clearing a tablet from Novo NordiskWSJ • 12/22/25
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Dec 2025)24/7 Wall Street • 12/21/25
Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSemaZacks Investment Research • 12/19/25
Novo Nordisk: Oral Wegovy, Supply Chain, And Restructuring = Big Upside AheadSeeking Alpha • 12/19/25
Can Higher-Dose Wegovy Help Novo Nordisk Regain Obesity Market Share?Zacks Investment Research • 12/18/25
CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU ApprovalZacks Investment Research • 12/15/25